240 related articles for article (PubMed ID: 20508839)
1. Sympathetic Neurotransmitters and Tumor Angiogenesis-Link between Stress and Cancer Progression.
Tilan J; Kitlinska J
J Oncol; 2010; 2010():539706. PubMed ID: 20508839
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
Medeiros PJ; Jackson DN
Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells.
Sigala B; McKee C; Soeda J; Pazienza V; Morgan M; Lin CI; Selden C; Vander Borght S; Mazzoccoli G; Roskams T; Vinciguerra M; Oben JA
PLoS One; 2013; 8(9):e72928. PubMed ID: 24019886
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
Kitlinska J; Abe K; Kuo L; Pons J; Yu M; Li L; Tilan J; Everhart L; Lee EW; Zukowska Z; Toretsky JA
Cancer Res; 2005 Mar; 65(5):1719-28. PubMed ID: 15753367
[TBL] [Abstract][Full Text] [Related]
5. Rapid measurement of cardiac neuropeptide dynamics by capacitive immunoprobe in the porcine heart.
Kluge N; Dacey M; Hadaya J; Shivkumar K; Chan SA; Ardell JL; Smith C
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H66-H76. PubMed ID: 33095651
[TBL] [Abstract][Full Text] [Related]
6. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y.
Lundberg JM; Pernow J; Franco-Cereceda A; Rudehill A
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S51-68. PubMed ID: 2455193
[TBL] [Abstract][Full Text] [Related]
7. Interactions between neuropeptide Y and adrenergic systems in the stimulation of luteinizing hormone release in steroid-primed ovariectomized rats.
Allen LG; Crowley WR; Kalra SP
Endocrinology; 1987 Dec; 121(6):1953-9. PubMed ID: 2824175
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization.
Kitlinska J
Cancer Lett; 2007 Jan; 245(1-2):293-302. PubMed ID: 16513255
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
Tilan J; Kitlinska J
Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Schwertfeger E; Klein T; Vonend O; Oberhauser V; Stegbauer J; Rump LC
Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):455-61. PubMed ID: 15103451
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine release in the immature ovary is regulated by autoreceptors and neuropeptide-Y.
Ferruz J; Ahmed CE; Ojeda SR; Lara HE
Endocrinology; 1992 Mar; 130(3):1345-51. PubMed ID: 1537296
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
[TBL] [Abstract][Full Text] [Related]
14. Beta-amyloid peptides undergo regulated co-secretion with neuropeptide and catecholamine neurotransmitters.
Toneff T; Funkelstein L; Mosier C; Abagyan A; Ziegler M; Hook V
Peptides; 2013 Aug; 46():126-35. PubMed ID: 23747840
[TBL] [Abstract][Full Text] [Related]
15. TH and NPY in sympathetic neurovascular cultures: role of LIF and NT-3.
Damon DH
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C306-12. PubMed ID: 18032527
[TBL] [Abstract][Full Text] [Related]
16. The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system.
Elenkov IJ; Wilder RL; Chrousos GP; Vizi ES
Pharmacol Rev; 2000 Dec; 52(4):595-638. PubMed ID: 11121511
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay.
Straub RH; Schaller T; Miller LE; von Hörsten S; Jessop DS; Falk W; Schölmerich J
J Neurochem; 2000 Dec; 75(6):2464-71. PubMed ID: 11080198
[TBL] [Abstract][Full Text] [Related]
18. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome.
Kuo LE; Czarnecka M; Kitlinska JB; Tilan JU; Kvetnanský R; Zukowska Z
Ann N Y Acad Sci; 2008 Dec; 1148():232-7. PubMed ID: 19120115
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of sympathetic neuron neuropeptide Y and catecholamine content and secretion.
May V; Brandenburg CA; Braas KM
J Neurosci; 1995 Jun; 15(6):4580-91. PubMed ID: 7790925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
